Author  
Place of duty  
Title   °æ°è¼º , ħÀ±¼º ¹× ÀüÀ̼º ³­¼Ò¾Ï¿¡¼­ ³ªÅ¸³ª´Â Class 1 ¹× Class 2 Àΰ£ ÁÖÁ¶Á÷ ÀûÇÕ¼º Ç׿øµéÀÇ ¹ßÇö ÀÌ»ó ( Alterations of HLA Class 1 and 2 Antigen Expressions in Borderline, Invasive and Metastatic Ovarian Cancers )
Publicationinfo   2000 Jan; 032(06): 1031-1043.
Key_word   Ovary neoplasm , HLA class 1 , HLA class 2
Full-Text  
Abstract   Purpose: The relationship between altered HLA expressions and ovarian carcinogenesis is not fully elucidated. Materials and Methods: Histological evaluation comprised 20 serous adenocarcinoma, 5 borderline serous malignancy, 10 mucinous adenocarcinoma, 15 borderline mucinous malignancy. We used monoclonal antibodys to HLA class I p2-microglobulin, class I B/C and class II heavy chain. Results: There was no statistical difference in HLA expressions between borderline serous malignancy and normal ovarian tissue. In serous adenocarcinoma, 02-microglobulin, B/C and class II heavy chain expressions were down-regulated. In metastatic cancer, B/C and class II expressions were also down-regulated. But the HLA expression of tumor or normal stromal tissue in primary tumor, were not down-regulated compared with the tissues in metastasis. In borderline mucinous malignancy, class II expressions were down-regulated. In mucinous adenocarcinoma, 2-microglobulin, B/C and class II expressions were down-regulated. In metastatic ovarian cancer, B/C and class II expressions were down-regulated. But, in borderline malignancy, the result failed to reach statistical significance except class II of borderline mucinous malignancy. Conclusion: Loss of HLA class I and II molecules in invasive ovarian cancers raises the possibility that this could be a mechanism for tumor cells to have invasiveness,
Àú ÀÚ   ±èÁø¿ì(Jin Woo Kim),±èÀ±°æ(Yun Kyong Kim),À¯¿µ¿Á(Young Oak Lew),Áö¼º¹è(Sung Bae Jee),±è±Ô¹®(Gyu Moon Kim),Ãֹ̿µ(Mi Young Choi),°­¹ÌÁö(Mi Ji Kang),ÀÌ¿ë¼®(Yong Seok Lee)